📲 bolttech: Powering Embedded Insurance

Singapore-based insurtech bolttech has closed its Series C funding round, raising $147 million and achieving a post-money valuation of $2.1 billion. The round welcomed new strategic investors Sumitomo Corporation and Iberis Capital, joining existing backers such as Dragon Fund, Baillie Gifford, and Generali’s Lion River.

🤝 Strategic Partnerships and Expansion
• Sumitomo Corporation, one of Japan’s largest trading houses, has not only invested in bolttech but also entered into a joint venture to deliver embedded insurance programs and end-to-end services across Asia.
• Iberis Capital, a Portuguese private equity and venture capital firm, brings its expertise to support bolttech’s growth in European markets.

🚀 Advancing Global Insurtech Solutions
• The new funding will enable bolttech to enhance its platform capabilities and accelerate its global growth strategy, aiming to make insurance more personalized, accessible, affordable, and convenient for customers.
• bolttech’s platform connects over 700 distribution partners with more than 230 insurers, offering a wide range of insurance products worldwide.

With this significant investment and strategic partnerships, bolttech is poised to further its mission of transforming the insurance industry through innovative embedded solutions.

📊 Powered by V3V Ventures

🚐 Plus: Bringing Autonomous Trucks to Wall Street

Autonomous trucking startup Plus is going public through a SPAC merger with Churchill Capital Corp IX, valuing the company at $1.2 billion. The deal will provide $300 million in gross proceeds and is expected to close by Q4 2025 — marking Plus’ second attempt at going public after a scrapped 2021 IPO.

🧠 Software-First Autonomy for Global OEMs
• Plus builds self-driving software for long-haul trucks, targeting global manufacturers like Traton, Hyundai, and Iveco.
• Its system is currently being tested on roads in Texas and Sweden, with full commercial rollout planned for 2027.
• The company’s stack can be deployed incrementally — starting with driver-assist features and progressing to full autonomy.

📉 Second Shot After Market Pullback
• In 2021, Plus walked away from a $3.3B SPAC due to market instability.
• The current $1.2B valuation reflects more tempered expectations — but also more clarity on product roadmap and partnerships.
• Market conditions for SPACs have improved, especially in high-capex, long-horizon sectors like autonomous transport.

📦 Solving Logistics’ Bottlenecks
• Trucking continues to face labor shortages and efficiency gaps, making autonomy a compelling solution.
• Plus believes its tech can reduce delivery times, improve safety, and cut costs for freight operators.
• Regulatory signals in the U.S. and EU are gradually favoring autonomous commercial vehicles.

As the race to autonomous logistics heats up, Plus is betting that patient engineering and deep OEM ties will help it outlast earlier hype cycles.

📊 Powered by V3V Ventures

🗃 Kargo Wants to Be the AI Brain of the Warehouse Dock

Kargo, a San Francisco-based startup using computer vision to modernize warehouse inventory, has raised an $18.4M Series A extension led by Matter Venture Partners. Strategic investors Lineage Logistics and Armada Supply Chain Solutions joined, alongside existing backers Founders Fund and Sozo Ventures.

🛠 Hardware-Enabled AI for Freight Accuracy
• Kargo builds dockside infrastructure — “Kargo Towers” and “Kargo Lifts” — outfitted with AI-powered cameras.
• The system scans incoming and outgoing freight, capturing label data, case counts, and visible damage.
• A proprietary large language model analyzes the footage to flag overages, shortages, and compliance issues in real time.

⚙️ Strategic Rollout with 3PL Giants
• Armada has installed Kargo across 240 dock doors in its U.S. network, a major signal of operational validation.
• Lineage’s participation ties Kargo to the world’s largest temperature-controlled logistics network.
• Kargo says its system brings “visual proof” to warehouse data — reducing disputes between shippers and carriers.

📈 From Warehouse Cameras to Supply Chain OS
• Kargo aims to evolve beyond hardware into a full software layer for logistics visibility.
• With growing data from docks, the startup is building tools to automate exception handling and inventory reconciliation.
• The model: capture raw physical events at the edge, then abstract insights upstream into ERP and TMS systems.

As legacy logistics players digitize their last blind spots, Kargo is betting that computer vision — not just barcodes — will power the next leap in supply chain intelligence.

📊 Powered by V3V Ventures

🧠 Oblong Pivots to Decentralized

Oblong Inc. (NASDAQ: OBLG), historically known for enterprise collaboration tools, is rebranding itself around AI and digital assets — raising $7.5M in a private placement to launch a Bittensor-centric strategy built around the $TAO token.

🔗 From Whiteboards to Permissionless Intelligence
• Oblong will acquire $TAO and build tools for Bittensor, a decentralized network rewarding machine learning contributions.
• The company plans to operate in subnet 0, earning yield by providing AI services on-chain.
• This marks a full pivot away from its Mezzanine™ collaboration platform into AI-native crypto infrastructure.

🪙 Token-Backed Capital Raise
• The $7.5M came from institutional investors at $3.77 per share, totaling 1.99M shares.
• As of Q1 2025, Oblong had $4.3M in cash and no debt — giving it a clean balance sheet to execute its new thesis.
• Proceeds will be used for $TAO accumulation and engineering around the Bittensor stack.

📉 Betting on the Third Era of Crypto
• Oblong believes crypto is entering its “AI phase,” following the monetary (Bitcoin) and smart contract (Ethereum) eras.
• Bittensor’s capped 21M token supply and incentive structure resemble early Bitcoin, but applied to compute.
• The firm sees $TAO as a potential foundational asset for decentralized AI coordination.

🎯 High-Risk, High-Conviction Rebrand
• Oblong is effectively transforming into a public vehicle for Bittensor exposure.
• Investors are betting on $TAO’s long-term upside and the firm’s ability to carve out technical value in the ecosystem.
• The move mirrors a growing number of crossover plays between public markets and open-source AI.

As AI and blockchain increasingly collide, Oblong is making a high-conviction wager: that the next trillion-dollar protocol may be owned — not built — by the ones who get in early.

📊 Powered by V3V Ventures

🔐 Infisical Wants to Be the OS for Developer Security

Infisical, a startup focused on developer-first secrets and identity management, has secured a $16 million Series A round led by CRV, with participation from Gradient Ventures, Operator Stack, and existing investors. The funding aims to expand its platform across secrets, identity, and access management.

🛠 Unified Platform for Secrets, Identity, and Access
• Infisical offers a centralized solution for managing secrets, identities, and access controls, designed to streamline security workflows for developers and DevOps teams.
• The platform integrates with various tools and services, providing seamless management of environment variables, API keys, and other sensitive information.
• By unifying these aspects, Infisical aims to reduce complexity and enhance security across development environments.

📈 Strategic Growth and Expansion
• With the new funding, Infisical plans to accelerate product development, focusing on enhancing its platform’s capabilities in secrets management and access control.
• The company intends to expand its team, particularly in engineering and customer support, to better serve its growing user base.
• Infisical also aims to increase its presence in the enterprise market, targeting organizations seeking robust and scalable security solutions.

As organizations increasingly prioritize security and compliance, Infisical’s approach to simplifying secrets and access management positions it as a key player in the evolving landscape of developer-centric security solutions.

📊 Powered by V3V Ventures

🧠 Vima Therapeutics Launches to Treat Dystonia at the Root

Vima Therapeutics, a neuroscience-focused biotech, has launched with a $60 million Series A led by Atlas Venture, with participation from Access Industries and Canaan. The company is advancing VIM0423, the first oral small molecule targeting the root cause of dystonia and related movement disorders.

🧬 Mechanism-Driven Oral Therapy for Movement Disorders
• VIM0423 selectively targets muscarinic cholinergic receptors in the brain, a pathway known to be disrupted in dystonia and related disorders.
• Existing treatments offer symptomatic relief but suffer from tolerability issues—Vima aims to address the underlying neural dysfunction.
• As an oral therapy, VIM0423 could offer a more accessible and patient-friendly alternative to injectable or device-based treatments.

👥 Led by Veteran Neuroscience Operators
• CEO Bernard Ravina, MD, is a movement disorder expert with experience at Voyager, Biogen, and Praxis.
• President and Head of R&D Judith Dunn, PhD, brings 30+ years in drug development, including senior roles at Roche.
• The leadership team also includes veterans from Surface Oncology, Takeda, and Wyeth, adding cross-functional experience in neurology and clinical operations.

📈 Advancing Toward Clinical Proof
• VIM0423 is currently in Phase 1 trials, with Phase 2 expected to launch in Q4 2025.
• The Series A funding will support continued clinical development, biomarker strategy, and platform expansion.
• Vima is initially targeting isolated dystonia but sees broader potential in related movement disorders like Parkinsonism and Tourette’s.

As the field shifts from symptom control to disease modification, Vima’s targeted, mechanism-based approach has the potential to redefine treatment for a historically underserved patient population.

📊 Powered by V3V Ventures

🧬 Biopeak Wants to Be the OS for Preventive Health in India

Biopeak, a Bengaluru-based longevity startup, has raised $3.5M in seed funding from Claypond Capital (Ranjan Pai), Accel’s Prashanth Prakash, Nikhil Kamath, and others. The funding will support clinic expansion and development of its AI-powered diagnostic platform.

🏠 Clinics That Combine Imaging, Genomics, and AI
• Offers full-body scans, molecular diagnostics, and microbiome analysis—all under one roof.
• Patients receive personalized health plans following 6+ hour clinical assessments.
• Uses AI to interpret multi-modal data and detect dysfunctions before symptoms appear.

📈 Scaling Healthspan Infrastructure
• Plans to open new clinics in major Indian cities.
• Targeting both wellness-focused consumers and those with unresolved chronic conditions.
• Collaborating with IISc and Longevity India to localize protocols for Indian health profiles.

Biopeak is building India’s first high-tech healthspan clinic network—where prevention, not treatment, takes center stage.

📊 Powered by V3V Ventures

🛡️ Anduril Is Building the Autonomy Stack for U.S. Defense

Anduril, the defense tech startup founded by Palmer Luckey, has raised $2.5B in Series G funding at a $30.5B valuation, nearly doubling its worth since 2023. Founders Fund led the round with a record $1B check, joined by Valor Equity, Andreessen Horowitz, and others. The raise includes a tender offer for early employees.

🤖 Full-Stack Autonomy for National Defense
• Builds AI-powered surveillance towers, autonomous drones, and software to fuse battlefield data.
• Focused on modular, scalable systems that integrate rapidly into military operations.
• Positions itself as the defense equivalent of Tesla + Palantir—owning both hardware and software layers.

💳 Biggest VC Bet in Defense Tech
• Revenue has doubled in the past year, approaching ~$1B in 2024.
• Oversubscribed 8x, indicating surging interest in dual-use and defense-aligned ventures.
• Tender offer provides early liquidity—a sign of long-term confidence from existing investors.

🌐 From Startup to Strategic Prime
• Competing with traditional defense primes by moving faster and iterating on battlefield feedback.
• Strong alignment with U.S. defense goals: autonomy, deterrence, and cost-effective deterrents.
• Long-term risks include geopolitical volatility, contract dependency, and intense regulatory scrutiny.

Anduril isn’t just a contractor—it’s positioning as a full-stack autonomy provider for the modern military.

📊 Powered by V3V Ventures

🔥 Dave’s Hot Chicken: From $900 Pop-Up to $1B Franchise Empire

Dave’s Hot Chicken, the spicy fast-casual brand born in a Los Angeles parking lot, has been acquired by Roark Capital in a deal reportedly worth close to $1 billion. What began as a $900 experiment in 2017 is now one of the fastest-growing restaurant chains in the world.

🍔Viral Flavor, Cult Brand
• Started with just a fryer, canopy, and folding table—sold $40 worth of food on day one.
• Known for its simple menu, extreme heat levels (waiver required!), and no-frills branding.
• Leveraged Instagram virality and celebrity fans (Drake is an investor) to fuel early hype.

⚖️ Scaling With Speed and Consistency
• Expanded to 315+ locations globally with 150 more in development.
• Franchised early, with partners often committing to multi-unit deals.
• Revenue tripled to $600M+ in two years—projected to double again by 2025.

🤝 Roark Capital Seals the Deal
• Roark—owner of Dunkin’, Wingstop, and Arby’s—has followed Dave’s since it hit 15 stores.
• Acquisition brings operational muscle and global franchising expertise.
• Founders remain involved: one leads culinary, the other brand—preserving authenticity.

Dave’s Hot Chicken is proof that a gritty, low-capital launch can scale into a global business with the right product, story, and speed. The question now: Can it keep its edge under private equity ownership?

📊 Powered by V3V Ventures

🥛 PFx Biotech: Allergy-Free Milk Proteins Made by Microbes

Porto-based PFx Biotech has raised €2.5M in grant funding from the European Innovation Council Accelerator to scale its production of human milk proteins—without cows. The startup is using precision fermentation to make infant-safe, allergen-free proteins for the next generation of nutrition products.

🧬 Proteins Inspired by Human Biology
• Produces lactoferrin, α-lactalbumin, and osteopontin using engineered microbes.
• Designed for infant formulas and medical nutrition—without cow allergens.
• Motivated by a founder’s personal experience raising a child with milk allergies.

🏠 Scaling With EU Backing
• Grant will fund bioreactor upgrades, regulatory approvals, and key hires.
• Targets commercialization of bioidentical lactoferrin as a lead ingredient.
• Alumni of Mylkcubator and EIT Food programs; part of the emerging alt-dairy deeptech scene.

🌍 Health, Sustainability, and Global Demand
• Eliminates reliance on animal agriculture while improving nutritional outcomes.
• Positioned for infant, senior, and functional food markets.
• Meets growing demand for hypoallergenic, sustainable protein sources.

PFx Biotech is rewriting the future of milk—replacing cows with microbes to create a cleaner, safer, and more precise source of nutrition.

📊 Powered by V3V Ventures

🧲 IonQ Acquires Oxford Ionics to Scale Quantum Hardware

IonQ is acquiring UK-based Oxford Ionics in a ~$1.1B all-stock deal, aiming to accelerate development of fault-tolerant quantum systems. The acquisition is set to close later in 2025.

🧪 Ion Traps Meet Scalable Manufacturing
• Oxford Ionics’ chips use electrode-based control, avoiding lasers — a key step for stability and mass production.
• Built on standard CMOS processes, the tech fits directly into semiconductor supply chains.
• Joint roadmap targets 256 high-fidelity qubits by 2026 and 80,000+ logical qubits by 2030.

👥 UK Talent and Global Reach
• The 80-person Oxford team, including its co-founders, will join IonQ and continue operations from the UK.
• The move deepens IonQ’s European footprint and supports partnerships with Airbus and UK quantum centers.

📈 Scaling Tech — and the Business
• IonQ, valued near $10B, has made 6 acquisitions since 2022 to consolidate its quantum stack.
• Post-deal, shares jumped up to 11%; 2025 revenue guidance: $75–95M.
• The company is transitioning from lab-scale systems to commercial-grade quantum processors.

This deal signals a pivot: the race to useful quantum computing will be won by those who can manufacture — not just innovate.

📊 Powered by V3V Ventures

💳 Meta Eyes Stake in Scale AI to Power GenAI Ambitions

Meta is in advanced talks to invest over $10 billion in Scale AI, the data infrastructure startup powering many of today’s leading AI models. The potential deal would mark one of the largest-ever investments by a tech giant in an external AI company.

📊 Fueling the Data Layer
• Scale AI provides high-quality training data for OpenAI, Microsoft, and Meta’s own LLaMA models.
• Its platform enables supervised fine-tuning, RLHF, and structured data labeling at enterprise scale.
• 2024 revenue reached ~$870M; 2025 target: over $2B.

🧠 Meta’s External Bet on AI Infrastructure
• The deal signals a shift from Meta’s build-it-alone AI strategy to strategic partnerships.
• Scale also supports Meta’s classified “Defense Llama” work — expanding its AI footprint into defense.
• The investment could give Meta long-term preferential access to Scale’s services and platform.

💵 Massive AI Capex, Broad Reach
• Meta plans to spend up to $68B this year on AI hardware, infrastructure, and product rollouts.
• Generative AI features are coming to Facebook, Instagram, and Meta Ads by 2026.
• A deepened alliance with Scale could sharpen Meta’s edge across consumer and enterprise AI use cases.

For Meta, this isn’t just about data — it’s about controlling the full stack of the AI value chain.

📊 Powered by V3V Ventures

🛡️ Guardz Brings Unified AI Cybersecurity to MSPs

Cybersecurity startup Guardz has raised a $56M Series B led by ClearSky, bringing total funding to $84M. The company is building an AI-native platform tailored for managed service providers (MSPs) serving SMBs.

🤖 Unified, AI-First Security Platform
• Combines endpoint, identity, email, cloud, and data protection in one console — backed by both AI and human-led threat response.
• Includes built-in integrations (e.g., SentinelOne) to cut alert fatigue and accelerate remediation.
• Adds extras like compliance automation, cyber insurance, and phishing simulations.

🚀 Growth Backed by Strong Demand
• Funds will go toward U.S. expansion, product development, and 24/7 MDR capabilities.
• Guardz aims to help MSPs turn cybersecurity into a scalable, recurring-revenue service.
• Already serving “hundreds of partners” across multiple countries.

🔓 Solving the SMB Security Gap
• Most SMBs lack in-house security teams and rely on fragmented tools.
• Guardz enables MSPs to deliver enterprise-grade protection with simplified management.
• Its AI-native design helps close detection and response gaps without adding overhead.

With fresh capital and a clear MSP-first focus, Guardz is betting that unified AI platforms will define the next generation of small-business cybersecurity.

📊 Powered by V3V Ventures

🧠 Glean Supercharges Enterprise AI

Enterprise AI startup Glean has raised a $150M Series F at a $7.2B valuation, led by Wellington Management. The company is building a Work AI platform that combines search, agents, and security to accelerate decision-making across large organizations.

🔍 Search + AI Agents for the Enterprise
• Connects to 100+ enterprise tools (e.g. Google Workspace, Slack, Salesforce) to unify company knowledge.
• Combines permission-aware search with agentic workflows — employees can ask, act, and generate in one interface.
• AI features are layered with robust security, including Glean Protect for data loss prevention and compliance.

📈 Scaling Fast With Fortune 500 Adoption
• Crossed $100M in ARR less than three years after launch.
• Powers over 100M agent actions per year — aiming to hit 1B annually by end of 2025.
• Customers include Databricks, Grammarly, Duolingo, Deutsche Telekom, and more.

💰 New Capital Fuels Global Expansion
• Funding will accelerate product development, AI innovation, and go-to-market expansion.
• Opening a San Francisco hub to complement its Palo Alto HQ.
• Aims to deepen enterprise partnerships and expand internationally.

🏠 Reinventing How Work Gets Done
• Glean positions itself as the “intelligence layer” for modern companies, unlike generalist tools like ChatGPT.
• Helps teams find answers, automate tasks, and securely collaborate — all from a single interface.
• Recognized by CNBC and Fast Company as a top innovator in enterprise tech.

With strong momentum and a growing market need, Glean is making a bold push to redefine how knowledge workers interact with data, AI, and each other inside the enterprise.

📊 Powered by V3V Ventures

⚙️ Linear Reimagines Developer Tools for the AI Era

Developer productivity startup Linear is building a fast, elegant alternative to Atlassian — now backed by a $1.25B valuation and fresh Series C funding led by Accel.

⚡ AI-Driven Workflows, Built for Speed
• Combines issue tracking, sprint planning, and bug triage in a minimalist interface loved by engineers.
• Includes built-in AI for auto-summarizing issues, suggesting priorities, and acting as a “team member.”
• Avoids noisy add-ons — streamlining software development with thoughtful design and performance.

📈 Profitable, Lean, and Growing Fast
• 280% revenue growth year-over-year, with just ~80 fully remote employees.
• Used by over 15,000 companies, including OpenAI, Ramp, Perplexity, and Notion.
• Profitable, despite a team structure that prioritizes quality over headcount.

🚀 Going Enterprise, Staying Opinionated
• New capital will fund expansion into larger orgs while maintaining a product-led growth model.
• Plans to deepen integrations and push further into enterprise AI automation.
• Investors see Linear as a breakout platform in a sea of bloated tools and generic AI features.

🧱 A Clean-Sheet Challenge to Atlassian
• Designed from scratch to avoid the complexity and inertia of legacy systems like Jira.
• AI is integrated where it helps — not for show — keeping engineers in flow.
• Positioned as the foundation for modern product teams in fast-scaling environments.

Linear is betting that speed, clarity, and deeply integrated AI will define the next generation of dev tools.

📊 Powered by V3V Ventures

🌍 Mistral Launches AI That Reasons in 8 Languages

French startup Mistral has unveiled Magistral, a new AI model built for chain-of-thought reasoning across multiple languages—part of its push to challenge U.S. dominance in foundational AI.

🛸 Native Multilingual Reasoning
• First model to natively think in eight languages—no translation layer needed
• Designed for logic-heavy tasks in math, law, code, and finance
• Offers transparent step-by-step outputs for traceability and trust

🚀 Benchmarks Built for the Real World
• Magistral Medium scored 73.6% on AIME 2024; 90%+ with majority voting
• Outperforms many closed models on multilingual benchmarks
• Open-source “Small” version (24B params) already released for developers

🇪🇺 A European Vision for Foundational AI
• Built in Paris with backing from the French government and EU ecosystem
• CEO Arthur Mensch aims to make Mistral Europe’s answer to OpenAI and Anthropic
• Emphasizes openness, sovereignty, and practical performance over scale hype

💰 Backed by Billions
• Valued at $6.2B just one year after launch
• Funded by top-tier investors like Lightspeed, Andreessen Horowitz, and General Catalyst
• Positioned as the most serious EU contender in the global model race

While Silicon Valley chases ever-larger LLMs, Mistral is betting on multilingual logic, transparency, and practical design to win the next era of foundational AI.

📊 Powered by V3V Ventures

🔓 Cyera Expands AI-Native Platform to Secure Enterprise Data

Israeli-American startup Cyera is doubling down on AI-powered data security, scaling its platform to meet the rising need for DSPM, DLP, and identity protection in the generative AI era—with a fresh $540M raise and a $6B valuation boost in just seven months.

🧠 Built for the AI Data Explosion
• Unified platform combines DSPM, DLP, and identity intelligence
• Automatically discovers, classifies, and secures sensitive enterprise data
• Tailored for AI-heavy environments like copilots and foundation models

📊 Enterprise Growth at Scale
• 353% YoY growth in Fortune 500 adoption
• Doubled headcount to ~800 across 10+ global hubs
• Tripled overall footprint in under 18 months

⚙️ Product-Led Expansion Strategy
• Acquired Trail Security for $162M to boost cloud threat detection
• Building toward end-to-end data visibility and compliance automation
• New capital supports global scale, M&A, and rapid product development

🎯 Backing from Tier-1 Investors
• Series E co-led by Georgian, Greenoaks, and Lightspeed
• Continued support from Accel, Sequoia, Cyberstarts, and others
• Valuation doubled from $3B to $6B since late 2024

🚫 No Rush to IPO
• CEO Yotam Segev says Cyera is “just getting started”
• Focused on long-term infrastructure building, not short-term exits

Cyera is becoming the security layer for the AI-first enterprise—automating what humans can’t as data and models scale out of control. Is it quietly building the next cybersecurity giant?

📊 Powered by V3V Ventures

🦾 Wandercraft Brings Self-Balancing Exoskeletons to Everyday Mobility

Paris-based robotics startup Wandercraft is launching Eve, the world’s first self-balancing personal exoskeleton designed to help wheelchair users walk again—without crutches or external support. After years of clinical success with Atalante X, the company is now targeting home and daily-life mobility.

🦿 Engineered for Independent Walking
• Eve offers hands-free walking—no crutches or walkers needed
• Built on Wandercraft’s Atalante X, used in 100+ rehab centers globally
• Designed for everyday use in homes, communities, and public spaces

🤖 Clinical-Grade Tech, Consumer-Ready Design
• Uses 12 active joints + AI-powered dynamic gait algorithms
• Real-time self-balancing mimics natural walking across terrain
• Trials show 100% task success and confident use after just 5 sessions

📈 Scaling into Healthcare & Robotics Markets
• $75M Series D supports launch of Eve by 2026
• Funds also scale Atalante X adoption and production
• Investing in development of Calvin-40, a humanoid robot for industry

🤝 Strategic Backing with Industrial Vision
• Series D co-led by Renault Group, Bpifrance, Teampact Ventures, Quadrant Management
• Renault partnership brings industrial design and manufacturing support
• Builds on France’s push for robotics leadership across healthcare and automation

🌍 Built in Paris, Designed for Global Impact
• Founded in 2012, now 70+ employees focused on exoskeletons and robotics
• Dual FDA clearances already achieved in stroke and spinal rehab
• Positioned to lead in personal mobility, not just clinical use

Wandercraft is reshaping assistive mobility from rehab centers to real life—combining robotics precision with human-centered design. Could Eve be the iPhone moment for exoskeletons?

📊 Powered by V3V Ventures

🤖 Outset Launches AI-Driven Interview Platform for Enterprise Insights

Boston-based startup Outset is transforming customer research with its AI agent-led interview solution, helping companies scale and accelerate insights through automated, interactive conversations.

🎤 AI Agents for Customer Conversations
• Deploys AI-powered agents to conduct interviews at scale
• Automatically captures verbal feedback and generates rich, structured insights
• Enables enterprises to gather research without manual moderation

📈 Research, Reinvention, and Real-Time Results
• Integrates with CRM tools to trigger interviews post-event or interaction
• AI handles scheduling, follow-ups, and transcription in a unified portal
• Promises faster turnaround and deeper analysis for product and CX teams

💰 $17M Series A Fuels Product Growth
• Raised $17 million in Series A funding to support infrastructure, R&D, and go-to-market expansion
• Founded by seasoned researchers and enterprise SaaS veterans
• Targets mid-to-large enterprises looking to modernize qualitative research

🌍 Scaling Across Industries
• Ideal for sectors where customer sentiment and qualitative nuance matter—think fintech, health tech, and B2B SaaS
• Positioned to challenge manual interview workflows and traditional tools

Outset is automating the qualitative voice-of-customer layer with AI agents that both talk and listen—getting remote, scalable, and fast feedback without sacrificing nuance. With Series A backing, it’s ready to bring enterprise research into the AI era.

📊 Powered by V3V Ventures

💰 Chime IPO Pops as Neobank Bets on Everyday Banking

Digital banking startup Chime raised $700M in its IPO at a valuation of $11.6B, marking one of the biggest public debuts in the consumer fintech space this year. Shares jumped 59% on day one, trading under the ticker CHYM.

📲 Neobank for the Everyday American
• Chime targets users earning under $100K/year, with 2/3 using it as their primary account.
• Offers fee-free checking and savings, with most revenue from interchange (“swipe”) fees.
• Simplicity is the strategy: 72% of revenue is from debit card use, not lending or credit.

📈 Real Revenue, Real Usage
• Q1 2025 revenue: $518.7M — up 32% YoY.
• Q4 net income: $12.9M, maintaining profitability.
• 8.6M monthly active users, with high app engagement (4–5 opens/day per user).

🛸 Retention Engine with Direct Deposit
• Over 90% of users stay once they set up direct deposit.
• Average user makes 55 transactions/month — strong for a consumer neobank.
• User acquisition driven by $1.4B in marketing between 2022–24, now leveraged by loyalty.

📉 IPO Valuation Reset, but Still a Leader
• $11.6B valuation is less than half of 2021’s $25B private round.
• Reflects fintech’s broader market correction — but Chime remains a category-defining player.
• Public debut seen as a potential bellwether for stalled fintech IPO pipeline.

⚠️ From Early Struggles to Public Market
• Nearly failed before Series B — over 100 VCs passed.
• Faced regulatory pushback in 2021 for calling itself a “bank.”
• Now profitable, scaled, and positioned as the everyman’s fintech.

As fintech IPOs cautiously return, Chime’s clean model, sticky users, and growth discipline offer a rare combination — but staying public-ready is the next challenge.

📊 Powered by V3V Ventures